TG Therapeutics Inc (TGTX)
Operating profit margin
| Dec 31, 2024 | Dec 31, 2023 | Dec 31, 2022 | Dec 31, 2021 | Dec 31, 2020 | ||
|---|---|---|---|---|---|---|
| Operating income | US$ in thousands | 41,929 | 20,633 | -192,839 | -344,770 | -273,594 |
| Revenue | US$ in thousands | 324,397 | 221,047 | 2,785 | 6,689 | 152 |
| Operating profit margin | 12.93% | 9.33% | -6,924.20% | -5,154.28% | -179,996.05% |
December 31, 2024 calculation
Operating profit margin = Operating income ÷ Revenue
= $41,929K ÷ $324,397K
= 12.93%
TG Therapeutics Inc has shown a fluctuating trend in its operating profit margin over the past five years. The company experienced significant losses with negative operating profit margins of -179,996.05% in December 2020, -5,154.28% in December 2021, and -6,924.20% in December 2022. However, there has been a positive turnaround in recent years, with the operating profit margin improving to 9.33% in December 2023 and further increasing to 12.93% in December 2024. This positive shift indicates that the company has been able to manage its operating expenses more effectively and generate higher profits relative to its revenues in the past two years.
Peer comparison
Dec 31, 2024